IARS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.709000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.219400E-01
Normal-vs-Stage2
9.740800E-01
Normal-vs-Stage3
1.754450E-01
Normal-vs-Stage4
7.035600E-01
Stage1-vs-Stage2
6.141400E-01
Stage1-vs-Stage3
4.515900E-02
Stage1-vs-Stage4
9.422400E-01
Stage2-vs-Stage3
1.005970E-01
Stage2-vs-Stage4
6.317800E-01
Stage3-vs-Stage4
6.250300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.386600E-01
Normal-vs-AfricanAmerican
9.768800E-01
Normal-vs-Asian
4.919200E-01
Caucasian-vs-AfricanAmerican
8.818200E-01
Caucasian-vs-Asian
1.934000E-01
AfricanAmerican-vs-Asian
4.121400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.684600E-01
Normal-vs-Female
9.610000E-01
Male-vs-Female
9.656600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.637400E-01
Normal-vs-Age(41-60Yrs)
6.826000E-01
Normal-vs-Age(61-80Yrs)
8.477200E-01
Normal-vs-Age(81-100Yrs)
8.343600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.022600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.774800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.574600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.499700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.692400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.663000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.908200E-01
Normal-vs-Daily Drinker
6.419400E-01
Normal-vs-Weekly Drinker
9.979200E-01
Normal-vs-Occasional Drinker
7.367800E-01
Normal-vs-Social Drinker
5.824000E-01
Non Drinker-vs-Daily Drinker
7.112800E-01
Non Drinker-vs-Weekly Drinker
3.826800E-01
Non Drinker-vs-Occasional Drinker
8.361600E-02
Non Drinker-vs-Social Drinker
3.460000E-02
Daily Drinker-vs-Weekly Drinker
5.773800E-01
Daily Drinker-vs-Occasional Drinker
1.370030E-01
Daily Drinker-vs-Social Drinker
9.307900E-02
Weekly Drinker-vs-Occasional Drinker
5.986000E-01
Weekly Drinker-vs-Social Drinker
3.620000E-01
Occasional Drinker-vs-Social Drinker
5.838800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.042400E-01
Normal-vs-Grade 2
9.098000E-01
Normal-vs-Grade 3
9.498000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.240200E-01
Grade 1-vs-Grade 3
4.766400E-01
Grade 1-vs-Grade 4
9.042400E-01
Grade 2-vs-Grade 3
3.073000E-01
Grade 2-vs-Grade 4
9.098000E-01
Grade 3-vs-Grade 4
9.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.869400E-01
Normal-vs-NonDiabetic
9.876400E-01
Diabetic-vs-NonDiabetic
4.667800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.663800E-01
Normal-vs-NoPancreatitis
9.959200E-01
Pancreatitis-vs-NoPancreatitis
5.547200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.167600E-01
Normal-vs-N1
9.573600E-01
N0-vs-N1
2.863600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.415800E-01
Normal-vs-TP53-NonMutant
7.704000E-01
TP53-Mutant-vs-TP53-NonMutant
5.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
